Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07152756

Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores

Sponsor: Fudan University

View on ClinicalTrials.gov

Summary

A prospective, single-center, observational study to compare the risk of gastric retention and endoscopic mucosal visibility between the exposure group (one-week discontinuation of semaglutide before EGD) and non-exposure group (no semaglutide use before EGD)

Official title: Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores: A Single-Center, Prospective, Observational Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

418

Start Date

2025-09-15

Completion Date

2028-09-15

Last Updated

2025-09-03

Healthy Volunteers

No

Interventions

PROCEDURE

Esophagogastroduodenoscopy

Assess the gastric retention and the endoscopic mucosal visibility score during esophagogastroduodenoscopy

Locations (1)

Huadong hospital, Fudan university

Shanghai, Shanghai Municipality, China